E

Epitomee Medical Ltd
TASE:EPIT

Watchlist Manager
Epitomee Medical Ltd
TASE:EPIT
Watchlist
Price: 938.2 ILS 3.33% Market Closed
Market Cap: 276.9m ILS
Have any thoughts about
Epitomee Medical Ltd?
Write Note

Epitomee Medical Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Epitomee Medical Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
E
Epitomee Medical Ltd
TASE:EPIT
Income from Continuing Operations
-$5.7m
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nano-X Imaging Ltd
NASDAQ:NNOX
Income from Continuing Operations
-$60.8m
CAGR 3-Years
-12%
CAGR 5-Years
-100%
CAGR 10-Years
N/A
B
Brainsway Ltd
TASE:BWAY
Income from Continuing Operations
-$4.2m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
5%
Inmode Ltd
NASDAQ:INMD
Income from Continuing Operations
$153.7m
CAGR 3-Years
1%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Income from Continuing Operations
$27.3m
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Income from Continuing Operations
-$8.3m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Epitomee Medical Ltd
Glance View

Market Cap
276.9m ILS
Industry
Health Care

Epitomee Medical Ltd. develops and manufactures medical devices for obesity. The firm operates directly in the field of development, production and commercialization of medical platforms that are divided into two areas: the area of medical devices for weight loss and overweight, including the development and production of medical devices packed in capsules and ingested; the area of solutions for the introduction of drugs through ingestion that allows patients to take various medications that can be administered today only by injections. Both of the Company's solutions are intended for ingestion for patients for self-use, under a doctor's prescription and are under development.

EPIT Intrinsic Value
267.19 ILS
Overvaluation 72%
Intrinsic Value
Price
E

See Also

What is Epitomee Medical Ltd's Income from Continuing Operations?
Income from Continuing Operations
-5.7m USD

Based on the financial report for Dec 31, 2023, Epitomee Medical Ltd's Income from Continuing Operations amounts to -5.7m USD.

What is Epitomee Medical Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
-22%

Over the last year, the Income from Continuing Operations growth was 63%. The average annual Income from Continuing Operations growth rates for Epitomee Medical Ltd have been -22% over the past three years .

Back to Top